Dynavax Technologies Corporation logo
Dynavax Technologies Corporation DVAX
$ 10.89 -0.09%

Quarterly report 2025-Q3
added 11-05-2025

report update icon

Dynavax Technologies Corporation Operating Cycle 2011-2025 | DVAX

Annual Operating Cycle Dynavax Technologies Corporation

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
512 556 150 189 1.8 K 870 483 - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
1.8 K 150 652

Quarterly Operating Cycle Dynavax Technologies Corporation

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
541 548 546 - 512 538 555 - 412 483 603 - 76.3 43.2 160 - 246 164 304 - 196 775 132 76.7 76.7 97.7 99.5 63.6 231 270 1.26 K 3.71 K 1.47 K 742 677 16.8 756 43.2 124 170 69.9 46.1 119 29.1 30 21.8 30.7 52.1 50.7 43.8 57.6 50.8 31.9 34.2 204 76.1 740 120 -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
3.71 K 16.8 350

Operating Cycle of other stocks in the Biotechnology industry

Issuer Operating Cycle Price % 24h Market Cap Country
AbbVie AbbVie
ABBV
356 $ 223.01 -0.99 % $ 395 B usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
154 - - $ 2.17 B usaUSA
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
31.5 $ 4.68 1.85 % $ 777 M canadaCanada
Aclaris Therapeutics Aclaris Therapeutics
ACRS
6.01 $ 3.38 3.21 % $ 261 M usaUSA
Acasti Pharma Acasti Pharma
ACST
1.97 - 4.01 % $ 150 M canadaCanada
Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc
ADAP
25 - -15.15 % $ 60.3 M britainBritain
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
12.8 - - $ 40.3 B usaUSA
Albireo Pharma Albireo Pharma
ALBO
40.8 - -0.23 % $ 916 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
61.7 - - $ 7.46 M israelIsrael
Aptorum Group Limited Aptorum Group Limited
APM
4.89 $ 1.33 -1.48 % $ 7.25 M chinaChina
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
32 - -1.52 % $ 24.7 M usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
206 $ 90.34 -1.28 % $ 96.9 B britainBritain
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
195 $ 25.76 0.19 % $ 1.25 B usaUSA
Anika Therapeutics Anika Therapeutics
ANIK
325 $ 9.53 -1.19 % $ 140 M usaUSA
Brickell Biotech Brickell Biotech
BBI
254 - -5.38 % $ 6.06 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
49.5 - 0.49 % $ 251 B cayman-islandsCayman-islands
Biogen Biogen
BIIB
452 $ 173.03 -2.55 % $ 25.2 B usaUSA
Bellicum Pharmaceuticals Bellicum Pharmaceuticals
BLCM
6.09 - -9.72 % $ 5.89 M usaUSA
Berkeley Lights Berkeley Lights
BLI
349 - -7.31 % $ 87 M usaUSA
Aytu BioScience Aytu BioScience
AYTU
360 $ 2.33 2.3 % $ 14.6 M usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
946 - -6.81 % $ 3.04 B usaUSA
Baudax Bio Baudax Bio
BXRX
126 - 0.59 % $ 63 K usaUSA
Catalyst Biosciences Catalyst Biosciences
CBIO
410 $ 15.32 5.73 % $ 1.01 B usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
104 - - - russiaRussia
ChromaDex Corporation ChromaDex Corporation
CDXC
114 - -0.88 % $ 598 M usaUSA
Axon Enterprise Axon Enterprise
AXON
116 $ 586.28 3.15 % $ 44.4 B usaUSA
Cerus Corporation Cerus Corporation
CERS
59.2 $ 2.14 13.23 % $ 395 M usaUSA
Caladrius Biosciences Caladrius Biosciences
CLBS
164 - -16.75 % $ 25.8 M usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
86.5 $ 28.33 0.5 % $ 1.82 M usaUSA
Clovis Oncology Clovis Oncology
CLVS
65.5 - -7.23 % $ 13 M usaUSA
Benitec Biopharma Benitec Biopharma
BNTC
141 $ 12.91 0.78 % $ 531 M usaUSA
Cytokinetics, Incorporated Cytokinetics, Incorporated
CYTK
177 $ 60.38 0.11 % $ 6.76 M usaUSA
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
2.1 K - - $ 2.18 B usaUSA
Biohaven Pharmaceutical Holding Company Ltd. Biohaven Pharmaceutical Holding Company Ltd.
BHVN
408 $ 11.55 8.86 % $ 747 M usaUSA